Amelioration of PXR-mediated CYP3A4 induction by mGluR2 modulators

Bioorg Med Chem Lett. 2018 Oct 15;28(19):3194-3196. doi: 10.1016/j.bmcl.2018.08.022. Epub 2018 Aug 20.

Abstract

This work describes the rational amelioration of Cytochrome P450 4/5 (CYP3A4/5) induction through the Pregnane-X Receptor (PXR) pathway in a series of compounds that modulate the metabotropic glutamate Receptor 2 (mGluR2) via an allosteric mechanism. The compounds were initially shown to induce CYP3A4/5 via the gold-standard induction assay measured in primary human hepatocytes. This was followed up by testing the compounds in a PXR assay which correlated well with the assay in primary cells. Further, one of the compounds was crystallized with PXR (pdb code 6DUP). Analysis of this co-crystal structure, together with previously published PXR co-crystal structures, lead to modification ideas. The compounds synthesized based on these ideas were shown not to be CYP3A4/5 inducers. The mGluR2 activity of the resulting compounds was maintained.

Keywords: CYP3A4/5 induction; PXR; X-ray; mGluR2.

MeSH terms

  • Allosteric Regulation
  • Animals
  • Crystallography, X-Ray
  • Cytochrome P-450 CYP3A / biosynthesis*
  • Enzyme Induction / physiology
  • Humans
  • Pregnane X Receptor / chemistry
  • Pregnane X Receptor / physiology*
  • Rats
  • Receptors, Metabotropic Glutamate / drug effects*

Substances

  • Pregnane X Receptor
  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor 2
  • Cytochrome P-450 CYP3A